MRPS Sample Clauses

MRPS. For purposes hereof, "Named Individual" shall include each non-employee director of LISB or any of its subsidiaries and each officer of LISB with the position of executive vice president or higher. For purposes of preparing the Disclosure Letter, the present value of the benefits payable under the Specified Compensation and Benefit Programs shall be determined as follows: (i) it shall be assumed that a change of control of LISB occurs on September 30, 1998 and that each person entitled to benefits under the Specified Compensation and Benefit Programs is discharged as of September 30, 1998; (ii) it shall be assumed that all compensation levels remain constant; (iii) it shall be assumed that the present value of any payment or benefit which would be due and payable before September 30, 1998 is equal to the amount of such payment or the cost of such benefit; (iv) the present value of any payment or benefit that would be due and payable after September 30, 1998 shall be computed using the interest rate specified by the applicable plan for purposes of valuing lump sum payments or if no rate is specified, an assumed interest rate of 6% per annum, compounded annually; and (v) that all accrued benefits under all tax-qualified plans are 100% vested. The entire present value of the benefits payable under the Specified Compensation and Benefit Programs is set forth on the Disclosure Schedule, which specifies the portion thereof that has been accrued as a liability on the financial statements of LISB as of February 28, 1998.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
MRPS. Departments and needs: the figure below represents the MRPS organigram.
Sample 1Sample 2
MRPS. MRPS aims to exploit the project’s results by expanding the current range of home care services provided to elderly to include the Miraculous-Life system. The project fits well in its care provision program providing for interventions set to enhance the autonomy, dignity, sense of purpose, and identity of the elderly. Furthermore, MRPS together with other partners of the consortium is interested to work out a commercialization plan of the overall project outcome after the project. MRPS will disseminate the project and its results to stakeholders and policy makers, organizing on-site visits, open days and press conferences, as well as presenting the project and the concept in different national exhibitions and events. It has to be mentioned here that based on the knowledge acquired in the project, a start-up was created by persons working in MRPS, associated with ergotherapists, for the use of tablet technologies in the domain of handicapped (in the large sense) children. Regarding the standardization strategy, two approaches are followed. On the one hand, get an overview and information about existing standards in the care and the ICT domain so that the project can use available standards in the organization and for the technical development of various components, especially regarding interoperability, scalability and connectivity of the system. On the other hand, we monitored existing and ongoing work in standardization bodies and organisations with a special focus on interoperability, virtual characters, Human-Computer- Interaction based on emotions and behaviour analysis. Moreover, the project worked and partners are working towards standards to ensure that the research and development activities, but also the organizational activities, related to standards are aligned with the existing and future trends. This all having in mind the ultimate goal to enlarge the business and exploitation possibilities for the system or system components. This chapter describes the existing standards relevant for the project, the standards used or which will be used by the partners and the future trends or next steps we see as a partner and as a consortium.
Sample 1Sample 2
MRPS. In Switzerland, several companies are selling specific management software solutions designed for nursing homes and health care organizations. Some of those solutions became a reference in this field and could be considered as being Swiss-French standards: Sadies26 and Opale27. Other minor solutions were also identified: id.Viva28, sainet erp29 and Hermès30. We strongly think that in order to bring successfully the Miraculous-Life solution in the Swiss-French market, business partners should ensure an efficient communication between the Miraculous-Life back-end and those existing management software solutions.
Sample 1Sample 2
MRPS. Used informative and privacy documents for the Pre-Trial and the Trials (see D6.2 REV Privacy Protection Plan): • Informative brochure for the Pre-Trials • Informative brochure for the Trials • Informative presentation for the Pre-Trials • Informed consent form for the Pre-Trials • Informed consent form for the Trials • Form for use of one’s image for both Pre-Trials and Trials • Form for use of equipment for Trials Finally, UNIGE and the ICT department of MRPS will set-up the Miraculous Life system, ensuring the proper functionality.
Sample 1
MRPS. MRPS aims to exploit the project’s results by expanding the current range of home care services provided to elderly to include the Miraculous-Life system. The project fits well in its care provision program providing for interventions set to enhance the autonomy, dignity, sense of purpose, and identity of the elderly. Furthermore, MRPS together with other partners of the consortium is interested to work out a commercialization plan of the overall project outcome after the project. MRPS will disseminate the project and its results to stakeholders and policy makers, organizing on-site visits, open days and press conferences, as well as presenting the project and the concept in different national exhibitions and events. Regarding contribution to standards, two approaches will be followed. On the one hand, the project will contribute in improving existing standards that are under development. On the other hand, it will put significant emphasis on paving the way for standards that are foreseeable in the future by monitoring existing and ongoing work in standardization bodies and organisations with a special focus on interoperability, virtual characters, Human- Computer-Interaction based on emotions and behaviour analysis. Moreover, the project will work towards standards to ensure that the research activities are aligned with the existing and future trends. The project partners will make use of their already participations in different international standardisation organizations, industry bodies and consortia (like Continua, ALLOA, CEN, IEEE, W3C), to contribute in the different standard activities (c.f. 3.1.1g.)
Sample 1
MRPS. ‌ The two pre-trials will be carried out in a supervised environment setting. The MRPS restaurant “Le Jardin des Iles” (xxxx://xxx.xxxxxxxxxxxxx.xx/) rents four seminar and conference rooms: Hodler, Hainard, Hachette and Fazy. The pre-trials will take place in these rooms. Figure 1: MRPS test environment
Sample 1
AutoNDA by SimpleDocs

Related to MRPS

  • Medi Cal/daily service logs and notes and other documents used to record provision of services provided by instructional assistants, behavior intervention aides, bus aides, and supervisors

  • Quality Assurance Program An employee shall be entitled to leave of absence without loss of earnings from her or his regularly scheduled working hours for the purpose of writing examinations required by the College of Nurses of Ontario arising out of the Quality Assurance Program.

  • Quality Assurance The parties endorse the underlying principles of the Company’s Quality Management System, which seeks to ensure that its services are provided in a manner which best conforms to the requirements of the contract with its customer. This requires the Company to establish and maintain, implement, train and continuously improve its procedures and processes, and the employees to follow the procedures, document their compliance and participate in the improvement process. In particular, this will require employees to regularly and reliably fill out documentation and checklists to signify that work has been carried out in accordance with the customer’s specific requirements. Where necessary, training will be provided in these activities.

  • Medical Verification The Town may require medical verification of an employee’s absence if the Town perceives the employee is abusing sick leave or has used an excessive amount of sick leave. The Town may require medical verification of an employee’s absence to verify that the employee is able to return to work with or without restrictions.

  • Quality Management Grantee will: 1. comply with quality management requirements as directed by the System Agency. 2. develop and implement a Quality Management Plan (QMP) that conforms with 25 TAC § 448.504 and make the QMP available to System Agency upon request. The QMP must be developed no later than the end of the first quarter of the Contract term. 3. update and revise the QMP each biennium or sooner, if necessary. Xxxxxxx’s governing body will review and approve the initial QMP, within the first quarter of the Contract term, and each updated and revised QMP thereafter. The QMP must describe Xxxxxxx’s methods to measure, assess, and improve - i. Implementation of evidence-based practices, programs and research-based approaches to service delivery; ii. Client/participant satisfaction with the services provided by Xxxxxxx; iii. Service capacity and access to services; iv. Client/participant continuum of care; and v. Accuracy of data reported to the state. 4. participate in continuous quality improvement (CQI) activities as defined and scheduled by the state including, but not limited to data verification, performing self-reviews; submitting self-review results and supporting documentation for the state’s desk reviews; and participating in the state’s onsite or desk reviews. 5. submit plan of improvement or corrective action plan and supporting documentation as requested by System Agency. 6. participate in and actively pursue CQI activities that support performance and outcomes improvement. 7. respond to consultation recommendations by System Agency, which may include, but are not limited to the following: i. Staff training; ii. Self-monitoring activities guided by System Agency, including use of quality management tools to self-identify compliance issues; and iii. Monitoring of performance reports in the System Agency electronic clinical management system.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Quality Management System Supplier hereby undertakes, warrants and confirms, and will ensue same for its subcontractors, to remain certified in accordance with ISO 9001 standard or equivalent. At any time during the term of this Agreement, the Supplier shall, if so instructed by ISR, provide evidence of such certifications. In any event, Supplier must notify ISR, in writing, in the event said certification is suspended and/or canceled and/or not continued.

  • COUNTY’S QUALITY ASSURANCE PLAN The County or its agent will evaluate the Contractor’s performance under this Contract on not less than an annual basis. Such evaluation will include assessing the Contractor’s compliance with all Contract terms and conditions and performance standards. Contractor deficiencies which the County determines are severe or continuing and that may place performance of the Contract in jeopardy if not corrected will be reported to the Board of Supervisors. The report will include improvement/corrective action measures taken by the County and the Contractor. If improvement does not occur consistent with the corrective action measures, the County may terminate this Contract or impose other penalties as specified in this Contract.

  • Supplier Diversity Seller shall comply with Xxxxx’s Supplier Diversity Program in accordance with Appendix V.

  • Quality Assurance/Quality Control Contractor shall establish and maintain a quality assurance/quality control program which shall include procedures for continuous control of all construction and comprehensive inspection and testing of all items of Work, including any Work performed by Subcontractors, so as to ensure complete conformance to the Contract with respect to materials, workmanship, construction, finish, functional performance, and identification. The program established by Contractor shall comply with any quality assurance/quality control requirements incorporated in the Contract.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!